BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3537810)

  • 1. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
    Tatemoto K; Efendić S; Mutt V; Makk G; Feistner GJ; Barchas JD
    Nature; 1986 Dec 4-10; 324(6096):476-8. PubMed ID: 3537810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivity of human pancreastatin and its localization in pancreas.
    Funakoshi A; Jimi A; Yasunami Y; Tateishi K; Funakoshi S; Tamamura H; Yajima H
    Biochem Biophys Res Commun; 1989 Mar; 159(3):913-8. PubMed ID: 2649103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas.
    Peiró E; Miralles P; Silvestre RA; Villanueva ML; Marco J
    Metabolism; 1989 Jul; 38(7):679-82. PubMed ID: 2661967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pancreastatin on pancreatic endocrine and exocrine secretion.
    Ishizuka J; Asada I; Poston GJ; Lluis F; Tatemoto K; Greeley GH; Thompson JC
    Pancreas; 1989; 4(3):277-81. PubMed ID: 2471966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreastatin inhibits insulin secretion and exocrine pancreatic secretion in the pig.
    Ahrén B; Pierzynowski SG; Weström B; Karlsson B
    Diabetes Res; 1990 Jun; 14(2):93-6. PubMed ID: 2134219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas.
    Holst JJ; Ostenson CG; Harling H; Messell T
    Diabetologia; 1990 Jul; 33(7):403-6. PubMed ID: 1976102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas.
    Funakoshi A; Miyasaka K; Kitani K; Tamamura H; Funakoshi S; Yajima H
    Biochem Biophys Res Commun; 1989 Feb; 158(3):844-9. PubMed ID: 2645871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreastatin inhibits insulin secretion from isolated rat islets: studies on its mechanism of action.
    Lindskog S; Skoglund G; Ahrén B
    Diabetes Res; 1992 Mar; 19(3):119-23. PubMed ID: 1286546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreastatin (33-49) enhances the priming effect of glucose in the rat pancreas.
    Sánchez-Margalet V; Goberna R
    Experientia; 1993 Jul; 49(6-7):551-2. PubMed ID: 8335081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of bovine pancreastatin.
    Nakano I; Funakoshi A; Miyasaka K; Ishida K; Makk G; Angwin P; Chang D; Tatemoto K
    Regul Pept; 1989 May; 25(2):207-13. PubMed ID: 2756155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of pancreastatin on insulin secretion and the exocrine pancreas in rats].
    von Schönfeld J; Müller MK; Neisius I; Geling M; Rünzi M; Goebell H
    Z Gastroenterol; 1991 Oct; 29(10):523-6. PubMed ID: 1781189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of porcine pancreastatin on secretion and biosynthesis of insulin and glucose oxidation of isolated rat pancreatic islets.
    Ostenson CG; Sandler S; Efendic S
    Pancreas; 1989; 4(4):441-6. PubMed ID: 2668932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreastatin-like immunoreactivity and insulin are released in parallel from the perfused porcine pancreas.
    Ostenson CG; Efendic S; Holst JJ
    Endocrinology; 1989 Jun; 124(6):2986-90. PubMed ID: 2656247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats.
    Miyasaka K; Funakoshi A; Yasunami Y; Nakamura R; Kitani K; Tamamura H; Funakoshi S; Fujii N
    Regul Pept; 1990 Apr; 28(2):189-98. PubMed ID: 1693005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term inhibitory effects of pancreastatin and diazepam binding inhibitor on pancreatic beta-cell deoxyribonucleic acid replication, polyamine content, and insulin secretion.
    Sjöholm A; Funakoshi A; Efendić S; Ostenson CG; Hellerström C
    Endocrinology; 1991 Jun; 128(6):3277-82. PubMed ID: 2036990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pancreastatin and chromogranin A on insulin release stimulated by various insulinotropic agents.
    Ishizuka J; Tatemoto K; Cohn DV; Thompson JC; Greeley GH
    Regul Pept; 1991 Jun; 34(1):25-32. PubMed ID: 1857778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PHI on hormonal secretion from perfused rat pancreas.
    Szecówka J; Tendler D; Efendić S
    Am J Physiol; 1983 Oct; 245(4):E313-7. PubMed ID: 6137956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo.
    Sánchez-Margalet V; Calvo JR; Lucas M; Goberna R
    Gen Pharmacol; 1992 Jul; 23(4):637-8. PubMed ID: 1397969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas.
    Ahrén B; Bertrand G; Roye M; Ribes G
    Acta Physiol Scand; 1996 Sep; 158(1):63-70. PubMed ID: 8876749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the insulinotropic activity of glucagon-superfamily peptides in rat pancreas perfusion.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Horm Metab Res; 1992 Oct; 24(10):458-61. PubMed ID: 1464409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.